NCT05559931View on ClinicalTrials.gov

Single and Repeat Doses of DMT in Healthy Subjects

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 13, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Stroke
Interventions
DRUG

N,N-Dimethyltryptamine

IV infusion over 6 hours

DRUG

Placebo

Placebo infusion over 6 hours

Trial Locations (1)

Unknown

Centre for Human Drug Research, Leiden

Sponsors
All Listed Sponsors
collaborator

Centre for Human Drug Research, Netherlands

OTHER

lead

Algernon Pharmaceuticals

INDUSTRY

NCT05559931 - Single and Repeat Doses of DMT in Healthy Subjects | Biotech Hunter | Biotech Hunter